Neurotech International Ltd
(ASX:NTI)
A$
0.077
0.007 (10%)
Market Cap: 78.34 Mil
Enterprise Value: 73.86 Mil
PE Ratio: 0
PB Ratio: 15.40
GF Score: 0/100 Neurotech International Ltd Phase I/II PANDAS/PANS Clinical Trial Results Presentation Transcript
Oct 06, 2023 / 01:00AM GMT
Release Date Price:
A$0.062
(-7.46%)
Thomas Duthy
Neurotech International Ltd - Executive Director
Presentation
Oct 06, 2023 / 01:00AM GMT
=====================
Corporate Participants
=====================
* Thomas Duthy
Neurotech International Ltd - Executive Director
=====================
-
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)